| CPC C07K 7/08 (2013.01) [A61K 38/10 (2013.01); A61K 47/55 (2017.08); A61K 47/64 (2017.08); A61K 47/65 (2017.08); A61P 35/00 (2018.01); A61K 31/40 (2013.01); A61K 31/5375 (2013.01); A61K 38/00 (2013.01)] | 11 Claims |
|
1. A peptide ligand comprising a polypeptide comprising the amino acid sequence
| ||||
or pharmaceutically acceptable salt thereof,
and a molecular scaffold covalently bound to the polypeptide at amino acids Ci, Cii, and Ciii;
wherein each of Ci, Cii and Ciii is independently cysteine or an amino acid isosteric and isoelectronic with cysteine;
X6 represents Pro;
X7 represents 1-naphthylalanine (1-Nal);
X8 represents D-Asp;
X9 represents Met;
X10 represents homoarginine (HArg);
X11 represents Asp;
X12 represents Trp;
X13 represents Ser;
X14 represents Thr;
X15 represents Pro;
X16 represents hydroxyproline (HyP); and
X17 represents Trp.
|